|
2025
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst... |
|
|
G/S
|
Medical information services, namely, providing information related to vaccines for C Difficile i... |
|
|
G/S
|
Medical syringes; Medical apparatus, namely, infusion and injection devices for administering drugs |
|
|
G/S
|
Downloadable software in the nature of a mobile application for tracking injections for the treat... |
|
|
G/S
|
Pharmaceutical preparations and substances; Medicinal preparations and substances; Vaccines. |
|
|
G/S
|
Medical apparatus, namely, infusion and injection devices for administering drugs; Medical syringes |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brai... |
|
2024
|
Invention
|
Multiplexed biological assay device with electronic readout.
This invention relates generally to... |
|
|
Invention
|
Antibodies and antibody-drug conjugates specific for cd123 and uses thereof.
The present inventi... |
|
|
Invention
|
Crystalline form of (2r)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2s)-7-methyl-6-(pyrimidin-2-yl)-3... |
|
|
Invention
|
Anti-migis-alpha antibodies and methods of use thereof. Provided herein are antibodies (including... |
|
|
Invention
|
Anti-migis-alpha antibodies and methods of use thereof.
Provided herein are antibodies (includin... |
|
|
Invention
|
A crystalline form of 6-fluoro-3-(2,4,5-trifluoro-3-methoxyphenyl)-1-benzothiophene-2-carboxylic ... |
|
|
Invention
|
Tissue factor pathway inhibitor antibodies and uses thereof.
The invention relates to antibodies... |
|
|
Invention
|
Oral controlled-release matrix formulations of 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl... |
|
|
Invention
|
Toll-like receptor agonists and conjugates thereof. The invention relates to compounds and immuno... |
|
|
Invention
|
Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product ... |
|
|
Invention
|
Chimeric antigen receptors targeting cd70.
The disclosure provides CARs (CARs) that specifically... |
|
|
Invention
|
Nitrile-containing antiviral compounds.
The invention relates to compounds of Formula I″
The i... |
|
|
Invention
|
Immunogenic compositions. The invention relates to lipid nanoparticles, immunogenic compositions ... |
|
|
Invention
|
Nitrogen-linked benzisoxazole sulfonamide derivatives.
The present invention relates to compound... |
|
|
Invention
|
Nitrogen-linked benzisoxazole sulfonamide derivatives for the treatment of cancer. The applicatio... |
|
|
Invention
|
Pyrido[4,3-d]pyrimidine compounds. The invention relates to compounds of Formula (I)-(III) and ph... |
|
|
Invention
|
Method for filling containers in sterile conditions with a pharmaceutical product and related fil... |
|
|
Invention
|
Methods and compositions for continuous production of nucleic acids. Described are methods, syste... |
|
|
Invention
|
Adjuvanted immunogenic compositions comprising conjugated pneumococcal capsular saccharide antige... |
|
|
Invention
|
Methods for producing an adjuvant. This invention provides methods for producing homogeneous adju... |
|
|
Invention
|
Immunogenic compositions against influenza. The invention relates to compositions and methods for... |
|
|
Invention
|
Escherichia coli compositions and methods thereof.
In one aspect, the invention relates to an im... |
|
|
Invention
|
Escherichia coli compositions and methods thereof.
This invention relates to compositions that i... |
|
|
Invention
|
Aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-... |
|
|
Invention
|
Vepdegestrant dosage regimen in cyp3a-inducer treatment in cancer. The invention relates to a met... |
|
|
Invention
|
Deuterated antiviral compounds.
The invention relates to compounds of Formula (I)
The inventio... |
|
|
Invention
|
Deuterated antiviral compounds. The invention relates to compounds of Formula (I) (I) wherein Y1a... |
|
|
Invention
|
Methods, therapies and uses for treating cancer. The present disclosure describes therapies and u... |
|
|
Invention
|
Injection device with an improved mechanism for generating an audible feedback. The invention rel... |
|
|
Invention
|
Klf2 inducing deuterated compounds and uses thereof.
The present disclosure provides deuterated ... |
|
|
Invention
|
Klf2 inducing compounds and uses thereof. The present disclosure provides compounds that are indu... |
|
|
Invention
|
Coronavirus antigen variants. The present disclosure provides isolated immunogenic polypeptides c... |
|
|
Invention
|
Lipid nanoparticles comprising polymer-conjugated lipids and uses thereof. Compounds are provided... |
|
|
Invention
|
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acryla-mides.
The... |
|
|
Invention
|
Amphiphilic tlr7/8 adjuvants and uses thereof.
The invention relates to compounds of Formula (I)... |
|
|
Invention
|
Amphiphilic tlr7/8 adjuvants and uses thereof. The invention relates to compounds of Formula (I) ... |
|
|
Invention
|
Antibodies specific for cd70 and their uses.
The present invention provides antibodies that spec... |
|
|
Invention
|
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the ... |
|
2023
|
Invention
|
Display screen or portion thereof with graphical user interface |
|
2022
|
Invention
|
Blister packaging for pharmaceuticals.
A blister package is disclosed herein. The blister packag... |
|
|
Invention
|
Combination therapies and uses for treating cancer.
The present disclosure relates to the treatm... |
|
|
Invention
|
Melanocortin 4 receptor antagonists and uses thereof.
Described herein are compounds of Formula ... |
|
|
Invention
|
Methods and dosing regimens comprising a cdk2 inhibitor for the treatment of cancer.
The disclos... |
|
|
Invention
|
Methods and dosing regimens comprising a cdk2 inhibitor and a cdk4 inhibitor for treating cancer.... |
|
|
Invention
|
Cdk4 inhibitor for the treatment of cancer.
The disclosure provides a method of treating cancer ... |
|
|
Invention
|
Solid forms of 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2s)-... |
|
|
Invention
|
Amorphous form of (s)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-n-(tetrahydrofuran-3-yl)pyrim... |
|
|
Invention
|
Diagnostic device with led display |
|
|
Invention
|
Dosing regime for treatment of chronic hand eczema.
Method for treating moderate to severe chron... |
|
2020
|
Invention
|
Treatment of hidradenitis with jak inhibitors.
There are methods for treating hidradenitis suppu... |
